Charles E Mahan

Charles E Mahan

UNVERIFIED PROFILE

Are you Charles E Mahan?   Register this Author

Register author
Charles E Mahan

Charles E Mahan

Publications by authors named "Charles E Mahan"

Are you Charles E Mahan?   Register this Author

30Publications

912Reads

23Profile Views

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.

Clin Appl Thromb Hemost 2018 May 8;24(4):575-582. Epub 2018 Mar 8.

6 Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health System, Hofstra Northwell School of Medicine, Manhasset, NY, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1076029618758955
Publisher Site
http://dx.doi.org/10.1177/1076029618758955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714693PMC
May 2018

Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.

Hosp Pract (1995) 2018 Feb 30;46(1):5-15. Epub 2017 Nov 30.

c Hofstra Northwell School of Medicine, Department of Medicine , Northwell Health System at Lenox Hill Hospital , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21548331.2018.1410053DOI Listing
February 2018

Venous thromboembolism: role of pharmacists and managed care considerations.

Am J Manag Care 2017 12;23(20 Suppl):S391-S398

View Article

Download full-text PDF

Source
December 2017

Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism.

Am J Med 2017 10 4;130(10):1137-1143. Epub 2017 Jul 4.

College of Pharmacy, University of Nebraska Medical Center, Omaha, Neb.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2017.06.004DOI Listing
October 2017

Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.

Curr Cardiol Rep 2017 10 24;19(12):124. Epub 2017 Oct 24.

Department of Internal Medicine, University of Michigan Medical School, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-017-0930-2DOI Listing
October 2017

Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.

Am J Med 2017 09 11;130(9):1015-1023. Epub 2017 May 11.

College of Pharmacy, University of Nebraska Medical Center, Omaha.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2017.04.015DOI Listing
September 2017

Reversing factor Xa inhibitors - clinical utility of andexanet alfa.

J Blood Med 2017 13;8:141-149. Epub 2017 Sep 13.

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JBM.S121550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602457PMC
September 2017

Cost-of-illness model for venous thromboembolism.

Thromb Res 2016 Sep 23;145:130-2. Epub 2016 Jun 23.

Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health System, Hofstra Northwell School of Medicine, Manhasset, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.06.022DOI Listing
September 2016

European Union-28: An annualised cost-of-illness model for venous thromboembolism.

Thromb Haemost 2016 Apr 26;115(4):800-8. Epub 2015 Nov 26.

Charles E. Mahan, PharmD, Pharmacist Clinician, Presbyterian Healthcare Services, Clinical Assistant Professor of Pharmacy, University of New Mexico, 1100 Central Ave. SE, Albuquerque, NM 87106, USA, Tel.: +1 505 841 1545, Fax: +1 505 841 1802, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-08-0670DOI Listing
April 2016

All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients.

Thromb Haemost 2015 Oct 23;114(4):685-94. Epub 2015 Jul 23.

Alex C Spyropoulos, MD, FACP, FCCP, FRCPC, Professor of Medicine, Hofstra North Shore-LIJ School of Medicine, 130 E &77th St 10075, Manhasset, NY, USA, Tel.: +1 212 434 6776, Fax: +1 212 434 6781, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-02-0108DOI Listing
October 2015

Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment.

Authors:
Charles E Mahan

J Thromb Thrombolysis 2015 Apr;39(3):295-303

Presbyterian Healthcare Services, University of New Mexico, 1100 Central Ave. SE, Albuquerque, NM, 87106, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-014-1164-4DOI Listing
April 2015

External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).

Thromb Haemost 2014 Oct 3;112(4):692-9. Epub 2014 Jul 3.

Alex C Spyropoulos, MD, FACP, FCCP, FRCPC, Director - Anticoagulation Services and Clinical Thrombosis, North Shore-LIJ Health System at Lenox Hill Hospital, Professor of Medicine, Hofstra North Shore-LIJ School of Medicine, Manhasset, New York, USA, Tel.: +1 212 434 6776, Fax: +1 212 434 6781, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH14-03-0239DOI Listing
October 2014

Stroke prevention in patients with atrial fibrillation and renal dysfunction.

Stroke 2014 Aug 26;45(8):2497-505. Epub 2014 Jun 26.

From the Hurley Medical Center, Flint, MI (S.K.); and New Mexico Heart Institute, Albuquerque, NM (C.E.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.114.005117DOI Listing
August 2014

Thrombophilia Issue.

J Pharm Pract 2014 06 16;27(3):224-6. Epub 2014 Apr 16.

Contributing Editor, Department of Pharmacy: Clinical and Administrative Sciences, The University of Oklahoma, Oklahoma City, OK, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190014530389DOI Listing
June 2014

A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents.

Authors:
Charles E Mahan

J Thromb Thrombolysis 2014 Apr;37(3):271-8

Presbyterian Healthcare Services, University of New Mexico, 1100 Central Ave. SE, Albuquerque, NM, 87106, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-013-0927-7DOI Listing
April 2014

Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.

Thromb Res 2013 Nov 28;132(5):520-6. Epub 2013 Aug 28.

Presbyterian Healthcare Services, University of New Mexico, Albuquerque, NM, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2013.08.013DOI Listing
November 2013

Antithrombotic medication use and bleeding risk in medically ill patients after hospitalization.

Clin Appl Thromb Hemost 2013 Sep 15;19(5):504-12. Epub 2013 Jan 15.

1Department of Outcomes Research, New Mexico Heart Institute, Albuquerque, NM, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029612470967DOI Listing
September 2013

Identifying, monitoring and reducing preventable major bleeds in the hospital setting.

J Thromb Thrombolysis 2013 Jul;36(1):7-13

New Mexico Heart Institute, University of New Mexico, 502 Elm Street NE, Albuquerque, NM 87102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-012-0819-2DOI Listing
July 2013

The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation.

Expert Opin Pharmacother 2013 Jun 11;14(9):1119-33. Epub 2013 Apr 11.

University of New Mexico Hospital, Inpatient Pharmacy Department, Albuquerque, NM, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2013.789022DOI Listing
June 2013

ASHP therapeutic position statement on the role of pharmacotherapy in preventing venous thromboembolism in hospitalized patients.

Am J Health Syst Pharm 2012 Dec;69(24):2174-90

New Mexico Heart Institute, Albuquerque, NM, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp120236DOI Listing
December 2012

Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery.

Pharmacotherapy 2012 Nov;32(11):1036-48

Department of Outcomes Research, New Mexico Heart Institute, University of New Mexico, 502 Elm Street NE, Albuquerque, NM 87102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1133DOI Listing
November 2012

Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitals.

Authors:
Charles E Mahan

Thromb Res 2012 Oct 28;130(4):586-90. Epub 2012 Jul 28.

New Mexico Heart Institute, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2012.07.001DOI Listing
October 2012

Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates.

Thromb Haemost 2012 Aug 28;108(2):291-302. Epub 2012 Jun 28.

New Mexico Heart Institute, University of New Mexico College of Pharmacy, Albuquerque, New Mexico 87102, USA.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1160/TH12-03-0162
Publisher Site
http://dx.doi.org/10.1160/TH12-03-0162DOI Listing
August 2012

Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis.

Clin Appl Thromb Hemost 2012 Jan-Feb;18(1):45-58. Epub 2011 Sep 23.

University of New Mexico Health Sciences Center, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131-0001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029611405186DOI Listing
June 2012

Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event.

Thromb Haemost 2011 Sep 11;106(3):405-15. Epub 2011 Aug 11.

University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH11-02-0132DOI Listing
September 2011

New antithrombotics: the impact on global health care.

Thromb Res 2011 Jun 6;127(6):518-24. Epub 2011 May 6.

University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2011.03.022DOI Listing
June 2011

Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.

Intern Emerg Med 2010 Aug 23;5(4):299-306. Epub 2010 Feb 23.

Cardinal Health Pharmacy Solutions, Lovelace Medical Center, Lovelace Rehabilitation Hospital, Lovelace Health Systems, 601 Dr. Martin Luther King Jr. Ave. NE, Albuquerque, NM, 87102, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11739-010-0359-8
Publisher Site
http://dx.doi.org/10.1007/s11739-010-0359-8DOI Listing
August 2010

Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient.

Hosp Pract (1995) 2010 Feb;38(1):97-108

Cardinal Health Pharmacy Solutions, Lovelace Medical Center, Albuquerque, NM 87102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/hp.2010.02.284DOI Listing
February 2010